Search
for
Sort by
Research 91–120 of 151
- Updates on Hirsutism: A Narrative Review
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Sex Differences in Opioid-Mediated Effects: Role of Androgens
- Transgender Competent Provider
- Exploring the clinical implications of novel SRD5A2 variants in 46,XY disorders of sex development
- Developmental and functional roles of androgen and interactive signals for external genitalia and erectile tissues
- Two years of innovative dermatological care: the first public health consultation service for the transgender and gender diverse community in Argentina
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Hirsutism in the Adolescent Female
- Distinctive Acne Entities
- The Hirsute Woman: Challenges in Evaluation and Management
- Nonsurgical Management of Facial Masculinization and Feminization
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Adverse health effects of androgen use
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Pharmacology of anabolic steroids
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Understanding Polycystic Ovary Syndrome
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- 46,XY DSD due to impaired androgen production
- Distinct Transcriptional Profiles of the Female, Male, and Finasteride-Induced Feminized Male Anogenital Region in Rat Fetuses
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Identification of a Rare Variant in the <i>SRD5A2</i> Gene in Siblings With 46,XY Disorders of Sexual Development
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- Table of Contents
- Gender-Affirming Hormonal Treatment in Transgender People Assigned Female at Birth (AFAB)